Learn / ALT
NASDAQ: ALT
Altimmune (ALT) stock, explained like you're 5
Altimmune trades on the Nasdaq under the ticker ALT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 508 million dollars.
- Ticker
- ALT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 508 million dollars
Is Altimmune a small, medium or large cap company?
No. Altimmune is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 508 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Altimmune makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ALT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Altimmune’s Investigational Therapy For Alcohol Use Disorder Meets Primary Endpoint ALT Stock Jumps 10% (Stocktwits)
- Is Altimmune Worth Buying as Cash Rises but Execution Risks Linger? (Yahoo Finance)
- CPST Stock Price, News & Analysis | Calamos S&P 500 Structured Alt Protection ETF September (Stock Titan)
- Calamos S&P 500 Structured Alt CPSA Stock Forecast & Price Target (Yahoo Finance)
- 10166908.SW Purchase Info | Investment Information for LO ALT BETA PC Stock (Yahoo! Finance Canada)
Follow ALT in your daily brief
Each trading day at 5 PM ET we post what happened to Altimmune and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ALT
Questions about Altimmune stock
What does Altimmune do?
Altimmune trades on the Nasdaq under the ticker ALT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 508 million dollars.
What is the ticker symbol for Altimmune?
Altimmune trades under the ticker ALT on the Nasdaq.
What is Altimmune's market cap?
Altimmune is a small cap stock with a market cap of about 508 million dollars.
How does Altimmune make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ALT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ALT stock every day?
Add ALT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.